NASAL ANTIHISTAMINES & ALLERGIC RHINITIS INDUCED SLEEP DISTURBANCES

鼻用抗组胺药

基本信息

项目摘要

One of the main manifestations of allergic rhinitis is congestion. Nasal congestion can predispose the individual to sleep apnea and microarousals. This sleep disturbance can result in daytime somnolence and fatigue. The use of nasal steroids has been effective at reducing congestion, both objectively and subjectively. Presently, no study is available that shows objective decrease in nasal resistance, sleep arousals, and daytime fatigue in association with nasal steroids. The key objectives of this study are to demonstrate that nasal steroids can decrease congestion resulting in less sleep disturbances and that reduction of sleep disturbances will result in a reduction of daytime fatigue and somnolence. 28 candidates with perennial allergic rhinitis will be selected for participation. They must have subjective findings of nasal obstruction and of sleep disturbances with associated daytime fatigue. This study will be a cross-over, double-blinded placebo controlled study over eight weeks. Each participant will begin the active phase of the study for four weeks with a crossover to the alternative arm of the study for four weeks. Procedures include a medical history, complete physical exam, rhinitis severity questionnaire, prick allergy skin testing, scale for sleep disfunction (Hoddes 1978) and daily diary for sleep, daytime fatigue and nasal symptoms.
过敏性鼻炎的主要表现之一是充血。鼻塞会使患者容易出现睡眠呼吸暂停和微觉醒。这种睡眠障碍会导致白天昏昏欲睡和疲劳。鼻腔类固醇的使用在客观上和主观上都有效地减少了充血。目前,还没有研究表明鼻腔阻力、睡眠唤醒和日间疲劳与鼻腔类固醇激素有关。这项研究的主要目的是证明鼻腔类固醇可以减少充血,从而减少睡眠干扰,减少睡眠干扰将减少白天的疲劳和嗜睡。常年性变应性鼻炎的28名候选人将被选中参加。他们必须有鼻塞和睡眠障碍的主观发现,并伴随着白天的疲劳。这项研究将是一项交叉、双盲、安慰剂对照研究,为期八周。每个参与者都将开始为期四周的研究活动阶段,并与研究的另一组交叉,为期四周。程序包括病史、全面的身体检查、鼻炎严重程度问卷、刺激性过敏皮肤测试、睡眠功能障碍量表(Hoddes 1978)和关于睡眠、白天疲劳和鼻部症状的每日日记。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy John Craig其他文献

Timothy John Craig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy John Craig', 18)}}的其他基金

ROLE OF PSEUDOEPHEDRINE ON PERENNIAL ALLERGIC RHINITIS & ASSOCIATED SLEEP
伪麻黄碱对常年性过敏性鼻炎的作用
  • 批准号:
    7951272
  • 财政年份:
    2009
  • 资助金额:
    $ 3.26万
  • 项目类别:
ROLE OF MONTELUKAST ON PERENNIAL ALLERGIC RHINITIS & ASSOCIATED SLEEP DISTURBANC
孟鲁司特对常年性过敏性鼻炎的作用
  • 批准号:
    7625744
  • 财政年份:
    2007
  • 资助金额:
    $ 3.26万
  • 项目类别:
RISK AND PREVENTION OF LARGE LOCAL REACTIONS TO INSECT STINGS
昆虫叮咬引起局部大规模反应的风险和预防
  • 批准号:
    7625752
  • 财政年份:
    2007
  • 资助金额:
    $ 3.26万
  • 项目类别:
INSECT STING ANAPHYLAXIS: DETERMINANT OF CLINICAL REACTIVITY
昆虫叮咬过敏:​​临床反应性的决定因素
  • 批准号:
    7378445
  • 财政年份:
    2006
  • 资助金额:
    $ 3.26万
  • 项目类别:
ROLE OF MONTELUKAST ON PERENNIAL ALLERGIC RHINITIS & ASSOCIATED SLEEP DISTURBANC
孟鲁司特对常年性过敏性鼻炎的作用
  • 批准号:
    7378467
  • 财政年份:
    2006
  • 资助金额:
    $ 3.26万
  • 项目类别:
RISK AND PREVENTION OF LARGE LOCAL REACTIONS TO INSECT STINGS
昆虫叮咬引起局部大规模反应的风险和预防
  • 批准号:
    7378482
  • 财政年份:
    2006
  • 资助金额:
    $ 3.26万
  • 项目类别:
INSECT STING ANAPHYLAXIS: DETERMINANT OF CLINICAL REACTIVITY
昆虫叮咬过敏:​​临床反应性的决定因素
  • 批准号:
    7203463
  • 财政年份:
    2005
  • 资助金额:
    $ 3.26万
  • 项目类别:
RISK AND PREVENTION OF LARGE LOCAL REACTIONS TO INSECT STINGS
昆虫叮咬引起局部大规模反应的风险和预防
  • 批准号:
    7203528
  • 财政年份:
    2005
  • 资助金额:
    $ 3.26万
  • 项目类别:
ROLE OF MONTELUKAST ON PERENNIAL ALLERGIC RHINITIS & ASSOCIATED SLEEP DISTURBANC
孟鲁司特对常年性过敏性鼻炎的作用
  • 批准号:
    7203507
  • 财政年份:
    2005
  • 资助金额:
    $ 3.26万
  • 项目类别:
Insect sting anaphylaxis--Clinical reactivity
昆虫叮咬过敏反应--临床反应性
  • 批准号:
    7044371
  • 财政年份:
    2003
  • 资助金额:
    $ 3.26万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.26万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 3.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了